Quality, purity, dosing, and contamination are real concerns with gray-market suppliers
Combination protocols pairing metabolic peptides with other interventions show promise
GHK-Cu Side Effects and Safety Potential concerns include: Skin irritation, redness, or sensitivity (with topical use) Variable absorption depending on formulation, but newer research has demonstrated that adding in a transport vessel such as liposomes can help with topical absorption (12)
[DOI] [PubMed] [Google Scholar] [111].Hudson JM, Cohen ND, Gibbs PG, Thompson JA
The careful description is therefore: Barrier and InfiniWell sell consumer-facing BPC supplements, but their products are not FDA-approved BPC-157 drugs and should not be described as though approval or legal status has been affirmatively settled by their availability
In 2023, GHK-Cu was placed on the FDA 503A list for compounded pharmaceutical substances under Category II restrictions